中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
13期
113-114
,共2页
鼻咽癌%PF方案%放射治疗%不良反应
鼻嚥癌%PF方案%放射治療%不良反應
비인암%PF방안%방사치료%불량반응
Nasopharyngeal carcinoma%PF regimen%Radiation therapy%Adverse reactions
目的探讨PF方案化疗同步放射治疗局部晚期鼻咽癌的疗效。方法将76例鼻咽癌患者分为:治疗组40例采用化疗﹢放射治疗,对照组36例采用单纯放射治疗。结果治疗组近期疗效CR﹢PR为92.5%,对照组CR﹢PR为69.5%;两组对比1、3、5年生存率无差异性(P﹥0.05),治疗组的毒副反应,主要是口腔粘膜炎、恶心、呕吐、白细胞下降、其中Ⅱ度及以上发生率分别为80%,35%及55%。对照组分别为25%,5.5%和0,两组对照有显著性差异(P﹤0.05)。结论 PF方案化疗同步放射治疗局部晚期鼻咽癌可以提高近期疗效,但毒副反应主要是口腔粘膜炎、恶心、呕吐、白细胞下降,PF方案并不能给患者带来好处。
目的探討PF方案化療同步放射治療跼部晚期鼻嚥癌的療效。方法將76例鼻嚥癌患者分為:治療組40例採用化療﹢放射治療,對照組36例採用單純放射治療。結果治療組近期療效CR﹢PR為92.5%,對照組CR﹢PR為69.5%;兩組對比1、3、5年生存率無差異性(P﹥0.05),治療組的毒副反應,主要是口腔粘膜炎、噁心、嘔吐、白細胞下降、其中Ⅱ度及以上髮生率分彆為80%,35%及55%。對照組分彆為25%,5.5%和0,兩組對照有顯著性差異(P﹤0.05)。結論 PF方案化療同步放射治療跼部晚期鼻嚥癌可以提高近期療效,但毒副反應主要是口腔粘膜炎、噁心、嘔吐、白細胞下降,PF方案併不能給患者帶來好處。
목적탐토PF방안화료동보방사치료국부만기비인암적료효。방법장76례비인암환자분위:치료조40례채용화료﹢방사치료,대조조36례채용단순방사치료。결과치료조근기료효CR﹢PR위92.5%,대조조CR﹢PR위69.5%;량조대비1、3、5년생존솔무차이성(P﹥0.05),치료조적독부반응,주요시구강점막염、악심、구토、백세포하강、기중Ⅱ도급이상발생솔분별위80%,35%급55%。대조조분별위25%,5.5%화0,량조대조유현저성차이(P﹤0.05)。결론 PF방안화료동보방사치료국부만기비인암가이제고근기료효,단독부반응주요시구강점막염、악심、구토、백세포하강,PF방안병불능급환자대래호처。
Objective To investigate the the PF regimen synchronization radiation treatment of locally advanced nasopharyngeal efficacy. Methods Patients were divided into 76 patients with nasopharyngeal carcinoma; treatment group, 40 cases were treated with chemotherapy plus radiation therapy, the control group 36 cases were treated with radiotherapy alone. Results The efficacy of the treatment group CR + PR 92.5%,was 69.5% in the control group CR + PR; toxicity of 1 -, 3 -, and 5-year survival rates of the two groups compared no differences (P> 0.05), treatment group, mainly oral mucositis, nausea, vomiting, leukopenia, Ⅱ degree and higher incidence of 80%, 35% and 55%. The control group were 25%, 5.5% and 0. The two groups were significant differences (P <0.05) Conclusion The PF regimen chemotherapy concurrent radiation therapy for locally advanced nasopharyngeal carcinoma can improve the short-term effect, but the degree of side effects mainly oral mucositis, dry mouth, nausea, vomiting, leukopenia, PF program does not give the patient the benefit of.